| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/11/2001 | WO2001002003A1 Method of treating psoriasis with il-15 antagonist |
| 01/11/2001 | WO2001001921A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 01/11/2001 | WO2001001786A2 Methods and means for producing improved dairy products |
| 01/11/2001 | WO2001001775A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 01/11/2001 | WO2001001766A1 Animal defective in uti gene function |
| 01/11/2001 | WO2001001749A2 FVIIa ANTAGONISTS |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000066739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2000066707A8 Novel thiamine transporter, a polynucleotide encoding same and their uses |
| 01/11/2001 | WO2000061793A3 Novel method for identifying antibacterial compounds |
| 01/11/2001 | WO2000061747A3 Clasp-2 transmembrane proteins |
| 01/11/2001 | WO2000059934A3 Testis specific protein |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000055208A3 Chimeric toxins |
| 01/11/2001 | WO2000054770A8 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis |
| 01/11/2001 | WO2000054731A3 Syndesmos and uses thereof |
| 01/11/2001 | WO2000053748A3 Casb618 polynucleotides and polypeptides and their use |
| 01/11/2001 | WO2000053216A3 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 01/11/2001 | WO2000053215A3 Deglycosylated ricin toxin a-chain vaccine |
| 01/11/2001 | WO2000052154A3 Methods and reagents for decreasing clinical reaction to allergy |
| 01/11/2001 | WO2000050075A3 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs |
| 01/11/2001 | WO2000047622A3 Peptides with anti-angiogenic activity |
| 01/11/2001 | WO2000039278A8 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 01/11/2001 | WO2000029561A8 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 01/11/2001 | WO2000029012A8 Methods of alleviating cancer symptoms |
| 01/11/2001 | WO1995016779A9 Herpes-symplex-virus type 2 icp4 protein and its use in a vaccine composition |
| 01/11/2001 | DE19931883A1 DNA kodierend für Beta-Tubulin und deren Verwendung DNA coding for beta-tubulin, and the use thereof |
| 01/11/2001 | DE19931380A1 Verfahren zur rekombinanten Herstellung von Ribonukleoproteinen A method for the recombinant production of ribonucleoproteins |
| 01/11/2001 | DE19931317A1 L-Lysin produzierende coryneforme Bakterien und Verfahren zur Herstellung von L-Lysin L-Lysine-producing coryneform bacteria and method for producing L-lysine |
| 01/11/2001 | DE19931314A1 L-Lysin produzierende coryneforme Bakterien und Verfahren zur Herstellung von Lysin L-Lysine-producing coryneform bacteria and method for preparing lysine |
| 01/11/2001 | DE19930570A1 Pflanzen mit veränderter Genexpression Plants with altered gene expression |
| 01/11/2001 | DE19930512A1 New human N-formyl receptor gene, useful for diagnosis and treatment of disease |
| 01/11/2001 | DE19929887A1 cDNA-Sequenzen von zwei Interakoren FANCIP2 und FANCIP3 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequences of two Interakoren FANCIP2 and FANCIP3 of the Fanconi anemia complementation group A-protein of the |
| 01/11/2001 | DE19926068C1 Muteine des Bilin-Bindungsproteins Muteins of the bilin-binding protein |
| 01/11/2001 | CA2750854A1 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 01/11/2001 | CA2590625A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phospho-transferase system proteins |
| 01/11/2001 | CA2590403A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate:sugar phospho-transferase system proteins |
| 01/11/2001 | CA2399045A1 Keratinocyte growth factor-2 |
| 01/11/2001 | CA2383943A1 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 01/11/2001 | CA2380875A1 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | CA2379477A1 Plants with modified gene expression |
| 01/11/2001 | CA2378951A1 Secreted protein zacrp4 |
| 01/11/2001 | CA2378539A1 Adenovirus carrying gag gene hiv vaccine |
| 01/11/2001 | CA2378477A1 Induction of immune tolerance |
| 01/11/2001 | CA2378153A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | CA2378143A1 The lactose operon of lactobacillus delbrueckii and its use for controlling gene transcription and/or expression in bacterial cells |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2377931A1 Novel mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | CA2377822A1 Means of stabilizing hemoglobin |
| 01/11/2001 | CA2377804A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 01/11/2001 | CA2377795A1 Use of the krit1 gene in angiogenesis |
| 01/11/2001 | CA2377791A1 Novel polypeptide and dna thereof |
| 01/11/2001 | CA2377788A1 Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor |
| 01/11/2001 | CA2377784A1 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 01/11/2001 | CA2377768A1 Method of identifying toxic agents using differential gene expression |
| 01/11/2001 | CA2377731A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 01/11/2001 | CA2377381A1 Neovascular-targeted immunoconjugates |
| 01/11/2001 | CA2377107A1 Delivery of trefoil peptides |
| 01/11/2001 | CA2376965A1 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 01/11/2001 | CA2376944A1 A substantially crystalline form of melagatran |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | CA2376166A1 Control of gene expression |
| 01/11/2001 | CA2374386A1 Plant proteins |
| 01/11/2001 | CA2374033A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 01/11/2001 | CA2373753A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 01/11/2001 | CA2373735A1 Fviia antagonists |
| 01/11/2001 | CA2372935A1 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/11/2001 | CA2372742A1 Double transgenic animals as models for neurodegenerative disease |
| 01/10/2001 | EP1067386A2 Inhibition of tau-tau-association |
| 01/10/2001 | EP1067194A1 Vectors containing a gene coding for CD40 and/or CD40L under the control of a cytokine-inducible promoter which is a human acute phase amyloid A gene promoter. Methods for their production and uses thereof |
| 01/10/2001 | EP1067193A1 L-lysine producing coryneform bacteria and methods for the production of L-lysine |
| 01/10/2001 | EP1067192A1 L-lysine producing coryneform bacteria and methods for the production of L-lysine |
| 01/10/2001 | EP1067188A1 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR) |
| 01/10/2001 | EP1067183A1 Novel g protein-coupled receptor proteins |
| 01/10/2001 | EP1067182A2 Secretory protein or membrane protein |
| 01/10/2001 | EP1067179A1 Method to select attenuated paramyxoviridae useful for vaccines and therapeutics |
| 01/10/2001 | EP1067141A1 A male-specific protein homologue involved in histocompatibility |
| 01/10/2001 | EP1067140A1 Novel hemolytic active proteins and genes encoding the same |
| 01/10/2001 | EP1066526A1 Pf-4 receptor assay |
| 01/10/2001 | EP1066398A1 Gpi-122, a novel glycophosphatidylinositol-anchored protein |
| 01/10/2001 | EP1066395A1 Inducible alphaviral gene expression system |
| 01/10/2001 | EP1066394A2 Novel basal endosperm transfer cell layer (betl) specific genes |
| 01/10/2001 | EP1066391A2 Antigen preparation and use |
| 01/10/2001 | EP1066390A2 Methods of cancer diagnosis using a chimeric toxin |
| 01/10/2001 | EP1066383A1 Porcine reproductive and respiratory syndrome oral vaccine production in plants |
| 01/10/2001 | EP1066382A1 Lens epithelial cell derived growth factor |
| 01/10/2001 | EP1066381A1 Human vanilloid receptor homologues |
| 01/10/2001 | EP1066380A2 Soluble t cell receptor |
| 01/10/2001 | EP1066379A1 Protein variant of the net1 locus |
| 01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
| 01/10/2001 | EP1066375A2 $i(LACTOBACILLI) HARBORING AGGREGATION AND MUCIN BINDING GENES AS VACCINE DELIVERY VEHICLES |
| 01/10/2001 | EP1066372A1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same |
| 01/10/2001 | EP1066328A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 01/10/2001 | EP1066327A2 Expression of fusion proteins |
| 01/10/2001 | EP1066326A1 Process for the preparation of thromboplastin from animal tissue |
| 01/10/2001 | EP1066325A1 G-protein fusion receptors and chimeric gaba b? receptors |
| 01/10/2001 | EP1066324A1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions |
| 01/10/2001 | EP1066323A1 Treatment and prevention of vascular disease |
| 01/10/2001 | EP1066322A1 Circularly permuted biotin binding proteins |
| 01/10/2001 | EP1066321A2 Formulation having a papilloma virus-specific protein, and the production and use thereof |